Colorectal Cancer Debate: First Line BRAF V600E - FOLFOXIRI/Bev

preview_player
Показать описание
Earn CME for related programs:

In this presentation from the '2019 Great Debates & Updates in Gastrointestinal Malignancies' in New York', Dr. Pashtoon M. Kasi argues in favor of utilizing FOLFOXIRI/Bev for the first-line treatment of BRAF V600E colorectal cancer.

© 2019 Imedex, an HMP Company
  1. HMP Education
  2. Imedex
  3. CME
  4. Continuing Medical Education
  5. Education
  6. Accreditation
Рекомендации по теме
Colorectal Cancer Debate: 0:04:51

Colorectal Cancer Debate: First Line BRAF V600E - FOLFOXIRI/Bev

Debate 1: First-line 0:13:18

Debate 1: First-line Treatment of Metastatic Colorectal Cancer - CALGB 80405

Debate 1: First-line 0:10:30

Debate 1: First-line Treatment of Metastatic Colorectal Cancer - FIRE-3

Colorectal Cancer Debate: 0:06:06

Colorectal Cancer Debate: First Line BRAF V600E - Targeted Triplet

Debate: MSI High 0:07:37

Debate: MSI High Colon Cancer - Upfront Chemotherapy

Selecting the optimal 0:12:16

Selecting the optimal first-line treatment in advanced colorectal cancer

Debate: Is there 0:08:36

Debate: Is there an optimal sequence for first-line therapy in mCRC? - Yes

Debate: Is there 0:08:05

Debate: Is there an optimal sequence for first-line therapy in mCRC? - No

Controversy Debate 4: 0:15:00

Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelines

Dr. McCollum on 0:01:39

Dr. McCollum on Treatment in the First-Line Setting for CRC

Debate: First line 0:08:20

Debate: First line EGFR therapy for left sided RAS/BRAF WT metastatic colon cancer? - Yes

Colon Cancer | 0:23:00

Colon Cancer | 2022 OneOncology Conference

First-line Targeted Therapies 0:04:33

First-line Targeted Therapies in Metastatic CRC

TRIBE Trial: First-Line 0:08:20

TRIBE Trial: First-Line Treatment of Metastatic Colorectal Cancer

Initial Management of 0:15:12

Initial Management of Metastatic CRC in 2019

Debate: Targeted therapy 0:11:54

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies

First-line drug therapy 0:36:11

First-line drug therapy selection strategy for metastatic colorectal cancer treatment

First- and Later-line 0:09:00

First- and Later-line Use of Panitumumab in Metastatic Colorectal Cancer

Colorectal Cancer: Sequencing 0:25:06

Colorectal Cancer: Sequencing and Therapeutic Approaches in First- and Next-Line Treatment

Add panitumumab or 0:07:31

Add panitumumab or bevacizumab to improve first-line metastatic colorectal cancer therapy?

DEBATES IN ONCOLOGY 7:42:53

DEBATES IN ONCOLOGY MANAGEMENT 2021

First-line therapy options 0:21:25

First-line therapy options in IBD: Understanding longitudinal severity

Drs. Subbiah, Beg, 1:40:22

Drs. Subbiah, Beg, Parikh, & Rashid discuss #GICancers at #GI23 - https://bit.ly/3WnYPut

Novel Agents and 0:22:10

Novel Agents and Targets in Colorectal Cancer